Published in PLoS One on April 07, 2011
Identification, characterization, and natural selection of mutations driving airborne transmission of A/H5N1 virus. Cell (2014) 2.23
Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog (2013) 1.64
The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus replication and pathogenesis in mice. J Virol (2013) 1.57
A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity. PLoS Pathog (2014) 1.29
Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets. J Virol (2013) 1.13
Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibility. J Gen Virol (2013) 1.05
Viral factors in influenza pandemic risk assessment. Elife (2016) 0.94
Characterization of H5N1 influenza virus variants with hemagglutinin mutations isolated from patients. MBio (2015) 0.87
The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines. J Virol (2014) 0.86
A histidine residue of the influenza virus hemagglutinin controls the pH dependence of the conformational change mediating membrane fusion. J Virol (2014) 0.85
Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture. J Virol (2011) 0.83
Use of ex vivo and in vitro cultures of the human respiratory tract to study the tropism and host responses of highly pathogenic avian influenza A (H5N1) and other influenza viruses. Virus Res (2013) 0.83
Amino Acid Substitutions That Affect Receptor Binding and Stability of the Hemagglutinin of Influenza A/H7N9 Virus. J Virol (2016) 0.82
Fecal influenza in mammals: selection of novel variants. J Virol (2013) 0.82
MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens. PLoS One (2012) 0.82
Influenza hemagglutinin (HA) stem region mutations that stabilize or destabilize the structure of multiple HA subtypes. J Virol (2015) 0.82
Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface. J Virol (2014) 0.80
pH-Dependent Formation and Disintegration of the Influenza A Virus Protein Scaffold To Provide Tension for Membrane Fusion. J Virol (2015) 0.79
Avian influenza virus NS1: A small protein with diverse and versatile functions. Virulence (2013) 0.78
H1N1 Swine Influenza Viruses Differ from Avian Precursors by a Higher pH Optimum of Membrane Fusion. J Virol (2015) 0.76
Modulation of the pH Stability of Influenza Virus Hemagglutinin: A Host Cell Adaptation Strategy. Biophys J (2016) 0.76
Refining the approach to vaccines against influenza A viruses with pandemic potential. Future Virol (2015) 0.75
Adaptation of avian influenza virus to a swine host. Virus Evol (2017) 0.75
Molecular determinants of influenza virus pathogenesis in mice. Curr Top Microbiol Immunol (2014) 0.75
Pyridones as NNRTIs against HIV-1 mutants: 3D-QSAR and protein informatics. J Comput Aided Mol Des (2013) 0.75
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03
Avian flu: influenza virus receptors in the human airway. Nature (2006) 11.28
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med (2006) 9.73
Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog (2009) 6.09
The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med (2006) 5.94
Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? J Virol (2005) 5.78
Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog (2007) 4.49
Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med (2007) 3.75
Aerosol transmission of influenza A virus: a review of new studies. J R Soc Interface (2009) 3.61
Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc Natl Acad Sci U S A (1997) 3.57
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr (2000) 3.53
Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev (1999) 3.41
Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog (2008) 3.37
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine (2001) 3.09
Infection of human airway epithelium by human and avian strains of influenza a virus. J Virol (2006) 3.02
Avian influenza virus in water: infectivity is dependent on pH, salinity and temperature. Vet Microbiol (2008) 2.59
Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull (2005) 2.58
Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport. J Virol (1994) 2.31
Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses. Am J Pathol (2010) 1.81
Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc Natl Acad Sci U S A (1991) 1.79
Submucosal glands and airway defense. Proc Am Thorac Soc (2004) 1.76
Mechanisms of acid and base secretion by the airway epithelium. J Membr Biol (2006) 1.57
Stability of infectious influenza A viruses at low pH and at elevated temperature. Vaccine (1985) 1.55
Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine (2009) 1.51
The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks. J Virol (2009) 1.50
Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J Virol (1995) 1.45
The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. Vaccine (2005) 1.42
Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin protein. J Virol (2009) 1.39
Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus. J Gen Virol (2007) 1.37
Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer. Hum Gene Ther (2002) 1.29
Avian Influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways. PLoS Pathog (2009) 1.27
Laboratory techniques in rabies: methods of calculation. Monogr Ser World Health Organ (1973) 1.26
Acid secretion and proton conductance in human airway epithelium. Am J Physiol Cell Physiol (2002) 1.22
Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: selection of hemagglutinin mutants with elevated pH of membrane fusion. Virology (1997) 1.20
A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1. J Infect Dis (2010) 1.18
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine (2006) 1.16
Airway surface pH in subjects with cystic fibrosis. Eur Respir J (2003) 1.15
Determination of baseline human nasal pH and the effect of intranasally administered buffers. Int J Pharm (2000) 1.10
Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses. Virol J (2007) 1.06
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine. PLoS One (2009) 1.04
Nasal pH measurement: a reliable and repeatable parameter. Clin Otolaryngol Allied Sci (1999) 1.00
Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts. J Virol (2006) 0.97
Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). Influenza Other Respir Viruses (2008) 0.95
Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1. Vaccine (2011) 0.90
China's chicken farmers under fire for antiviral abuse. Nature (2005) 0.89
Stability of infectious influenza A viruses to treatment at low pH and heating. Arch Virol (1985) 0.85
Twenty-four hour ambulatory nasal pH monitoring. Clin Otolaryngol Allied Sci (1999) 0.79
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One (2008) 6.98
A flexible flow sensor system and its characteristics for fluid mechanics measurements. Sensors (Basel) (2009) 2.92
Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. J Cell Sci (2002) 2.32
Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53. J Natl Cancer Inst (2009) 2.09
Osteoarthritis - an untreatable disease? Nat Rev Drug Discov (2005) 1.93
Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood (2002) 1.83
Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. J Gen Virol (2005) 1.78
Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs. Virology (2003) 1.70
Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J Virol (2002) 1.63
Novel swine-origin influenza A virus in humans: another pandemic knocking at the door. Med Microbiol Immunol (2009) 1.60
Anti-tumor mechanisms of valproate: a novel role for an old drug. Med Res Rev (2002) 1.54
Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J Control Release (2003) 1.54
A molecular switch between alternative conformational states in the complex of Ran and importin beta1. Nat Struct Biol (2003) 1.52
The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia (2009) 1.49
A new, simple method for linking of antibodies to atomic force microscopy tips. Bioconjug Chem (2007) 1.48
Rescue of influenza virus expressing GFP from the NS1 reading frame. Virology (2004) 1.45
Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol (2004) 1.44
Valproic acid inhibits angiogenesis in vitro and in vivo. Mol Pharmacol (2004) 1.41
Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence. Trends Microbiol (2003) 1.39
Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion (2007) 1.38
Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies. Med Res Rev (2005) 1.38
Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol (2010) 1.36
The clinical value of neutrophil extracellular traps. Med Microbiol Immunol (2009) 1.34
Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3. Cancer Res (2009) 1.34
Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proc Natl Acad Sci U S A (2005) 1.33
Detection of HSP60 on the membrane surface of stressed human endothelial cells by atomic force and confocal microscopy. J Cell Sci (2005) 1.26
Specific Inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci (2004) 1.24
Multiple receptors involved in human rhinovirus attachment to live cells. Proc Natl Acad Sci U S A (2008) 1.23
Molecular recognition imaging and force spectroscopy of single biomolecules. Acc Chem Res (2006) 1.23
Aircraft aerodynamic parameter detection using micro hot-film flow sensor array and BP neural network identification. Sensors (Basel) (2012) 1.22
Linking of sensor molecules with amino groups to amino-functionalized AFM tips. Bioconjug Chem (2011) 1.21
Direct measurement of protein energy landscape roughness. EMBO Rep (2005) 1.21
Histone deacetylase inhibitors suppress natural killer cell cytolytic activity. FEBS Lett (2007) 1.20
Nano-scale dynamic recognition imaging on vascular endothelial cells. Biophys J (2007) 1.19
A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1. J Infect Dis (2010) 1.18
Comparison of different aminofunctionalization strategies for attachment of single antibodies to AFM cantilevers. Ultramicroscopy (2007) 1.17
Glass surfaces grafted with high-density poly(ethylene glycol) as substrates for DNA oligonucleotide microarrays. Langmuir (2006) 1.17
Burst discharge in primary sensory neurons: triggered by subthreshold oscillations, maintained by depolarizing afterpotentials. J Neurosci (2002) 1.17
N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. Biochem Pharmacol (2009) 1.16
Past, present and future of atomic force microscopy in life sciences and medicine. J Mol Recognit (2007) 1.14
Single molecule recognition of protein binding epitopes in brush border membranes by force microscopy. Biophys J (2002) 1.14
Desmocollin 3-mediated binding is crucial for keratinocyte cohesion and is impaired in pemphigus. J Biol Chem (2009) 1.13
Simultaneous topography and recognition imaging using force microscopy. Biophys J (2004) 1.12
[Schistosomiasis status in People's Republic of China in 2010]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi (2011) 1.12
Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model. Int J Cancer (2003) 1.12
Valproic acid as anti-cancer drug. Curr Pharm Des (2007) 1.11
Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J Antimicrob Chemother (2007) 1.11
Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2. Genome Res (2010) 1.10
Single molecule studies of antibody-antigen interaction strength versus intra-molecular antigen stability. J Mol Biol (2005) 1.10
Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses. Med Microbiol Immunol (2010) 1.09
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines. Biochem Pharmacol (2009) 1.09
Higher dispersion efficacy of functionalized carbon nanotubes in chemical and biological environments. ACS Nano (2010) 1.09
Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion. Acta Ophthalmol (2011) 1.08
Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression. Int J Oncol (2005) 1.08
Interlaboratory round robin on cantilever calibration for AFM force spectroscopy. Ultramicroscopy (2011) 1.08
A geographic information and remote sensing based model for prediction of Oncomelania hupensis habitats in the Poyang Lake area, China. Acta Trop (2005) 1.06
The threat of avian influenza A (H5N1). Part IV: Development of vaccines. Med Microbiol Immunol (2007) 1.06
Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression. PLoS One (2011) 1.06
Determination of risk of infection with blood-borne pathogens following a needlestick injury in hospital workers. Ann Occup Hyg (2008) 1.05
Influenza virus binds its host cell using multiple dynamic interactions. Proc Natl Acad Sci U S A (2012) 1.05
Neutrophils and the blood-brain barrier dysfunction after trauma. Med Res Rev (2007) 1.04
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine. PLoS One (2009) 1.04
Antibody linking to atomic force microscope tips via disulfide bond formation. Bioconjug Chem (2006) 1.03